• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYHS2202096 马昔腾坦片 macitentan Tablet Chemical Drugs(4) Generic Drug 2022-12-27 QILU Pharmaceutical Co Ltd view
CYHS2303558 马昔腾坦片 macitentan Tablet Chemical Drugs(4) Generic Drug 2023-12-22 Shandong Hubble Kisen Biological Technology Co Ltd;Anhui Taienkang Pharmaceutical Co Ltd view
JXHB2101066 马昔腾坦片 macitentan Tablet Chemical Drugs(2.4) Supplementary Application 2021-09-13 Patheon Italia SpA;Actelion Pharmaceuticals Ltd view
JTH2400125 马昔腾坦分散片 macitentan Tablet Chemical Drugs Disposable Import Drug Application 2024-08-02 Xian Janssen Pharmaceutical Ltd;Excella GmbH;Janssen-Cilag International NV view
JXHB2101036 马昔腾坦分散片 macitentan Tablet Chemical Drugs(2.2) Supplementary Application 2021-07-05 Idorsia Pharmaceuticals Ltd;Actelion Pharmaceuticals Ltd view
JXHB2300036 马昔腾坦分散片 macitentan Tablet Chemical Drugs(2.2) Supplementary Application 2023-02-18 Idorsia Pharmaceuticals Ltd;Actelion Pharmaceuticals Ltd view
JXHB2200147 马昔腾坦片 macitentan Tablet Chemical Drugs(2.2) Supplementary Application 2022-09-20 Excella GmbH;Actelion Pharmaceuticals Ltd view
JXHB2300102 马昔腾坦片 macitentan Tablet Chemical Drugs(2.2) Supplementary Application 2023-06-14 Excella GmbH;Actelion Pharmaceuticals Ltd view
JYHB2500149 马昔腾坦片 macitentan Tablet Chemical Drugs Supplementary Application 2025-03-12 Excella GmbH;Actelion Pharmaceuticals Ltd view
JXHL2300281 马昔腾坦他达拉非片 macitentan;tadalafil Tablet Chemical Drugs(2.3) Import Drug Application 2023-11-10 Actelion Pharmaceuticals Ltd;Johnson & Johnson (CHINA) Investment Ltd view
JXHB2200106 马昔腾坦片 macitentan Tablet Chemical Drugs Supplementary Application 2022-08-01 Actelion Pharmaceuticals Ltd;Patheon France view
JXHB2200075 马昔腾坦分散片 macitentan Tablet Chemical Drugs(2.2) Supplementary Application 2022-06-16 Idorsia Pharmaceuticals Ltd;Actelion Pharmaceuticals Ltd view
JXHB2101038 马昔腾坦分散片 macitentan Tablet Chemical Drugs(2.2) Supplementary Application 2021-07-05 Idorsia Pharmaceuticals Ltd;Actelion Pharmaceuticals Ltd view
JXHB2300037 马昔腾坦分散片 macitentan Tablet Chemical Drugs(2.2) Supplementary Application 2023-02-18 Idorsia Pharmaceuticals Ltd;Actelion Pharmaceuticals Ltd view
JTH2400080 马昔腾坦他达拉非片 macitentan;tadalafil Tablet Chemical Drugs Disposable Import Drug Application 2024-06-08 Johnson & Johnson Pharmaceutical Co Ltd;Janssen-Cilag AG;Penn Pharmaceutical Services Ltd view
JXHB2300103 马昔腾坦片 macitentan Tablet Chemical Drugs(2.2) Supplementary Application 2023-06-14 Excella GmbH;Actelion Pharmaceuticals Ltd view
JYHZ2500048 马昔腾坦片 macitentan Tablet Chemical Drugs License Renew 2025-03-08 Johnson & Johnson;Excella GmbH;Actelion Pharmaceuticals Ltd view
JTH2200103 马昔腾坦 macitentan Active ingredient Chemical Drugs Disposable Import Drug Application 2022-06-03 Shandong Hubble Kisen Biological Technology Co Ltd view
JXHB2300136 马昔腾坦片 macitentan Tablet Chemical Drugs(2.2) Supplementary Application 2023-08-29 Excella GmbH;Actelion Pharmaceuticals Ltd view
JYHB2200590 马昔腾坦片 macitentan Tablet Chemical Drugs Supplementary Application 2022-11-01 Excella GmbH;Actelion Pharmaceuticals Ltd view